SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $512,878 | +8.0% | 3,958 | -7.9% | 0.01% | 0.0% |
| Q3 2022 | $475,000 | +52.7% | 4,297 | +3.6% | 0.01% | +66.7% |
| Q2 2022 | $311,000 | -29.6% | 4,147 | -26.6% | 0.01% | -14.3% |
| Q1 2022 | $442,000 | -13.7% | 5,653 | -0.6% | 0.01% | 0.0% |
| Q4 2021 | $512,000 | -12.6% | 5,689 | -24.6% | 0.01% | -22.2% |
| Q3 2021 | $586,000 | 0.0% | 7,542 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $586,000 | +49.9% | 7,542 | +43.9% | 0.01% | +33.3% |
| Q1 2021 | $391,000 | -72.6% | 5,241 | -37.3% | 0.01% | -72.7% |
| Q4 2020 | $1,425,000 | +125.5% | 8,356 | +85.6% | 0.02% | +100.0% |
| Q3 2020 | $632,000 | – | 4,502 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |